Mycophenolate Mofetil Sandoz (Mycophenolate Mofetil)

Mycophenolate Mofetil is employed in the management of immune‑mediated conditions, particularly in transplant and autoimmune settings.

• Prevention of acute organ transplant rejection: reduces the risk of graft rejection in kidney, heart and liver transplants.
• Treatment of lupus nephritis: helps control renal inflammation in systemic lupus erythematosus.
• Maintenance immunosuppression after transplantation: supports long‑term graft survival by sustaining immune suppression.

• Mycophenolate Mofetil is a pro‑drug that is converted to mycophenolic acid, which reversibly inhibits inosine monophosphate dehydrogenase (IMPDH). This enzyme blockade depletes guanosine nucleotides, selectively suppressing proliferation of T‑ and B‑lymphocytes and thereby dampening the adaptive immune response.

Adverse reactions may range from mild to severe and should be monitored throughout therapy.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: frequent loose stools.
• Headache: transient cranial discomfort.
• Abdominal pain: cramping or discomfort in the stomach area.
• Upper respiratory infections: increased susceptibility to colds and sinusitis.

Serious or Rare Side Effects

• Leukopenia: significant reduction in white blood cells.
• Anemia: decreased red blood cell count leading to fatigue.
• Severe infections: opportunistic infections such as pneumonia or sepsis.
• Hepatic dysfunction: elevated liver enzymes or hepatitis.
• Malignancy risk: potential increased risk of certain cancers with long‑term use.
• Progressive multifocal leukoencephalopathy (PML): rare but life‑threatening brain infection.

Patients receiving Mycophenolate Mofetil should be closely monitored for safety and efficacy.

• Monitor blood counts: regular CBC to detect leukopenia or anemia.
• Assess renal function: adjust therapy if creatinine rises.
• Check liver enzymes: watch for hepatic toxicity.
• Avoid live vaccines: increased risk of vaccine‑derived infection.
• Pregnancy and breastfeeding: safety unknown; discuss risks with a healthcare professional.
• Store at below 25°C: keep in the original container, protect from moisture and light.

Mycophenolate Mofetil can interact with several medicines, altering its effectiveness or safety.

Major Interactions (Avoid)

• Azathioprine: additive bone‑marrow suppression may cause severe cytopenias.
• Cyclosporine or tacrolimus: combined immunosuppression raises infection risk.
• Live vaccines: heightened chance of vaccine‑derived disease.

Moderate Interactions (Monitor Closely)

• Antacids containing aluminum or magnesium: may reduce absorption of mycophenolic acid.
• Rifampin or other strong enzyme inducers: can lower drug levels, reducing efficacy.